Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AstraZeneca PLC | Stockholm | Healthcare | Pharmaceuticals | SEK 2.12T | 28x | 1.26 | SEK 1,369 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.4% Upside | Upgrade to Pro+ | |
Swedish Orphan Biovitrum | Stockholm | Healthcare | Pharmaceuticals | SEK 101.05B | 25.5x | 0.32 | SEK 294.20 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.7% Upside | Upgrade to Pro+ | |
Sectra | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 69.98B | 123.9x | 3.96 | SEK 363.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.8% Downside | Upgrade to Pro+ | |
Getinge B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 51.25B | 34.6x | -0.98 | SEK 188.20 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.7% Upside | Upgrade to Pro+ | |
Asker Healthcare AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 40.48B | 67.2x | SEK 105.68 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.4% Downside | Upgrade to Pro+ | ||
Camurus AB | Stockholm | Healthcare | Pharmaceuticals | SEK 40.44B | 72.6x | 4.18 | SEK 680.50 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.6% Upside | Upgrade to Pro+ | |
Medicover | Stockholm | Healthcare | Healthcare Providers & Services | SEK 39.25B | 113.8x | 3.11 | SEK 260 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.3% Downside | Upgrade to Pro+ | |
Vimian Group AB | Stockholm | Healthcare | Pharmaceuticals | SEK 22.56B | 95.7x | 0.9 | SEK 42.84 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
AddLife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 21.76B | 71x | 0.24 | SEK 178.60 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
Bonesupport | Stockholm | Healthcare | Pharmaceuticals | SEK 20.52B | 166.4x | -2.93 | SEK 311.60 | 5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45% Upside | Upgrade to Pro+ | |
Vitrolife | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 20.07B | 40.3x | 0.35 | SEK 148.20 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Implantica AG | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 18.44B | -35.4x | SEK 65.10 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.9% Downside | Upgrade to Pro+ | ||
Elekta B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 18.35B | 77.2x | -0.95 | SEK 48.02 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.4% Upside | Upgrade to Pro+ | |
BioArctic | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 16.40B | 18.1x | 0.02 | SEK 185.30 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
RaySearch Labs B | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 12.39B | 55.7x | 0.45 | SEK 361.50 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.8% Downside | Upgrade to Pro+ | |
Biotage AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 11.39B | 44.8x | 10.67 | SEK 142.30 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioGaia B | Stockholm | Healthcare | Pharmaceuticals | SEK 10.86B | 35x | -2.07 | SEK 107.40 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.1% Upside | Upgrade to Pro+ | |
Ambea | Stockholm | Healthcare | Healthcare Providers & Services | SEK 9.79B | 16.1x | 0.48 | SEK 119.30 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.5% Upside | Upgrade to Pro+ | |
Arjo | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 9.55B | 22.1x | -1.4 | SEK 35.06 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Attendo International publ AB | Stockholm | Healthcare | Healthcare Providers & Services | SEK 9.38B | 19.9x | 0.58 | SEK 66.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Surgical Science Sweden | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.63B | 54x | -1.67 | SEK 149.50 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.4% Upside | Upgrade to Pro+ | |
Swedencare | Stockholm | Healthcare | Pharmaceuticals | SEK 7.54B | 80.6x | 2.68 | SEK 47.20 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.5% Upside | Upgrade to Pro+ | |
Xvivo Perfusion AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 7.04B | 63.1x | -5.82 | SEK 223.40 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CellaVision AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 4.31B | 28.4x | 3.64 | SEK 180.60 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.1% Upside | Upgrade to Pro+ | |
Medistim ASA | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 3.91B | 34x | 1.73 | SEK 210.31 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intellego Technologies AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 3.68B | 18.3x | 0.59 | SEK 119.60 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Flerie AB | Stockholm | Healthcare | Pharmaceuticals | SEK 3.42B | -10.4x | -0.16 | SEK 46 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.1% Upside | Upgrade to Pro+ | |
Cereno Scientific | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.68B | -25.8x | 0.37 | SEK 9.50 | 7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medivir B | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.58B | -1.8x | -0.08 | SEK 2.04 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BICO Group | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.47B | -8.1x | -0.1 | SEK 35 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioInvent International | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.36B | -5x | 0.12 | SEK 35.80 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Devyser Diagnostics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.23B | -24.9x | 0.62 | SEK 134.60 | 3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.7% Upside | Upgrade to Pro+ | |
Hansa Biopharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.20B | -2.8x | -0.09 | SEK 25.98 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carasent AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.15B | -60.3x | 0.29 | SEK 29.75 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.8% Downside | Upgrade to Pro+ | |
Stille AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 2.05B | 33.6x | 2.47 | SEK 228 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
XSpray Pharma | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 2.01B | -7.2x | 5.07 | SEK 54.10 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.9% Downside | Upgrade to Pro+ | |
Egetis Therapeutics AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.86B | -5.1x | -0.23 | SEK 5.17 | 9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Humana | Stockholm | Healthcare | Healthcare Providers & Services | SEK 1.86B | 9.7x | 0.35 | SEK 37.30 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.6% Upside | Upgrade to Pro+ | |
Genovis AB | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.79B | 75.6x | -3.35 | SEK 27.30 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.3% Upside | Upgrade to Pro+ | |
Vicore Pharma Holding AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.74B | -4x | -0.61 | SEK 7.43 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paxman | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.65B | 68.1x | -7.25 | SEK 77.20 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.1% Upside | Upgrade to Pro+ | |
OssDsign | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.60B | -29.9x | -0.47 | SEK 14.66 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Diamyd Medical | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.31B | -5.6x | 0.77 | SEK 9.52 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dicot | Stockholm | Healthcare | Pharmaceuticals | SEK 1.29B | -7x | -0.53 | SEK 0.64 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Saniona AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.27B | 4.8x | 0.02 | SEK 9.18 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.3% Upside | Upgrade to Pro+ | |
C-Rad | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.15B | 35.8x | -1.09 | SEK 34.20 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.7% Upside | Upgrade to Pro+ | |
Sedana Medical | Stockholm | Healthcare | Healthcare Equipment & Supplies | SEK 1.14B | -20.8x | 0.14 | SEK 11.46 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynAct Pharma AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.05B | -8x | -0.2 | SEK 21.15 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.4% Upside | Upgrade to Pro+ | |
Nanoform Finland Plc | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 1.02B | -3.8x | -0.31 | SEK 12.18 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cantargia AB | Stockholm | Healthcare | Biotechnology & Medical Research | SEK 999.42M | -4.7x | -0.04 | SEK 4.02 | 254.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |